Aurigene Pharmaceutical Services to set up ₹328 crore facility in Hyderabad

Hyderabad offers an excellent ecosystem for biologics Research and Development with 30-40 per cent of total capacity for biologics in India, said KTR.

Aurigene Pharmaceutical Services Ltd will establish its state-of-the art biomanufacturing facility at an investment of Rs 328 crore here, which will generate employment to more than 250 people.

Telangana Minister for IT and Industries KT Rama Rao in a tweet said Hyderabad offers an excellent ecosystem for biologics Research and Development with 30-40 per cent of total capacity for biologics in India.

Also Read: Bausch + Lomb to buy Novartis eye drop for $1.75 billion

“I’m happy to note that this investment has further bolstered Hyderabad's status as the top choice for biopharmaceutical research and production. I’m confident that we will continue to make significant strides in promoting "Complex manufacturing at scale," he said in the tweet.

Aurigene Pharmaceutical Services is a city-based leading contract research, development, and manufacturing organization (CRO/CDMO) and a long-term partner providing end-to-end solutions thereby accelerating innovation.